Editorial & Opinion
Developing expert consensus for the use of hedgehog inhibitors in basal cell nevus syndrome.
العنوان: | Developing expert consensus for the use of hedgehog inhibitors in basal cell nevus syndrome. |
---|---|
المؤلفون: | Lukowiak TM; Center for Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, NJ, USA. tess.lukowiak@gmail.com., Cahn B; Department of Dermatology, University of Illinois Chicago, Chicago, IL, USA., Samie F; Department of Dermatology, Columbia University, New York, NY, USA., Leffell DJ; Department of Dermatology, Section of Dermatologic Surgery, Yale University, New Haven, CT, USA., Oro A; Department of Dermatology, Stanford University, Redwood City, CA, USA., Kibbi N; Department of Dermatology, Stanford University, Redwood City, CA, USA., Kheterpal M; Department of Dermatology, Duke University, Durham, NC, USA., Babakoohi S; Atrium Health Levine Cancer Institute, Wake Forest School of Medicine, Charlotte, NC, USA., Khushalani NI; Moffitt Cancer Center, Tampa, FL, USA., Stephenson A; Patient representative, Texas, USA., Ma MS; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Shi VJ; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Ahmed A; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Koza E; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Haq M; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Yi MD; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Nadir U; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Yoo S; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Brieva JC; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Lucas J; Department of Dermatology, Cleveland Clinic, Cleveland, OH, USA., Haber R; Department of Dermatology, University of Illinois Chicago, Chicago, IL, USA., Alam M; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. |
المصدر: | Archives of dermatological research [Arch Dermatol Res] 2024 Jul 05; Vol. 316 (7), pp. 453. Date of Electronic Publication: 2024 Jul 05. |
نوع المنشور: | Letter |
اللغة: | English |
بيانات الدورية: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-069X (Electronic) Linking ISSN: 03403696 NLM ISO Abbreviation: Arch Dermatol Res Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Berlin : Springer Verlag |
مواضيع طبية MeSH: | Hedgehog Proteins*/antagonists & inhibitors , Hedgehog Proteins*/metabolism , Basal Cell Nevus Syndrome*/drug therapy , Basal Cell Nevus Syndrome*/diagnosis , Basal Cell Nevus Syndrome*/pathology , Consensus* , Skin Neoplasms*/drug therapy , Skin Neoplasms*/diagnosis , Skin Neoplasms*/pathology, Humans ; Anilides/therapeutic use ; Pyridines/therapeutic use ; Signal Transduction/drug effects |
References: | Gorlin RJ (2004) Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med 6(6):530–539. (PMID: 10.1097/01.GIM.0000144188.15902.C415545751) Tang JY, Mackay-Wiggan JM, Aszterbaum M et al (2012) Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 366(23):2180–2188. (PMID: 10.1056/NEJMoa1113538226709044362529) Bordeaux J, Blitzblau R, Aasi SZ (2024) Basal cell skin Cancer, Version 3.2024, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Canc Netw. Sekulic A, Migden MR, Lewis K et al (2015) Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. J Am Acad Dermatol 72(6):1021–1026e1028. (PMID: 10.1016/j.jaad.2015.03.02125981002) Migden MR, Guminski A, Gutzmer R et al (2015) Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol 16(6):716–728. (PMID: 10.1016/S1470-2045(15)70100-225981810) |
فهرسة مساهمة: | Keywords: Basal cell carcinoma; Basal cell nevus syndrome; Gorlin syndrome; Hedgehog inhibitors; Multidisciplinary care |
المشرفين على المادة: | 0 (Hedgehog Proteins) 0 (HhAntag691) 0 (Anilides) 0 (Pyridines) |
تواريخ الأحداث: | Date Created: 20240705 Date Completed: 20240705 Latest Revision: 20240705 |
رمز التحديث: | 20240705 |
DOI: | 10.1007/s00403-024-03157-z |
PMID: | 38967654 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1432-069X |
---|---|
DOI: | 10.1007/s00403-024-03157-z |